Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2010
06/22/2010US7741326 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands
06/22/2010CA2541131C Derivatives of piperazine, process for their preparation and pharmaceutical compositions containing them
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2441398C Lipid lowering biphenylcarboxamides
06/22/2010CA2428603C Prevention of development of dyskinesias with an alfa 2-adrenoceptor antagonist
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2412718C Viral polymerase inhibitors
06/17/2010WO2010068863A2 Pyrimidine compounds and methods of making and using same
06/17/2010WO2010068242A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/17/2010WO2010068171A1 A process for the preparation of 3- [ (2r) tetrahydrofuran-2- ylmethyl] -2-thioxo-l, 2, 3, 7-tetrahydro-6h-purin-6-one
06/17/2010US20100152465 Functionalized Ionic Liquids, and Methods of Use Thereof
06/17/2010US20100152458 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivatives
06/17/2010US20100152443 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient
06/17/2010US20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152160 Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010CA2744124A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/16/2010EP2195310A1 Luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof
06/16/2010EP2195296A1 Quinoline derivatives as 5ht5a receptor antagonists
06/16/2010EP2194787A1 Vegfr inhibitors containing a zinc binding moiety
06/16/2010EP1966167B1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
06/16/2010EP1963311B1 Chromane substituted benzimidazoles and their use as acid pump inhibitors
06/16/2010EP1914229B1 Novel cercosporamide derivative
06/16/2010EP1735302B1 4-amino-piperidine derivatives as monoamine uptake inhibitors
06/16/2010EP1492526B1 Conjugated prodrugs of cc-1065 analogs
06/16/2010CN1835946B Epoxy compound and cured epoxy resin product
06/16/2010CN1829711B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing them
06/16/2010CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
06/16/2010CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives
06/16/2010CN101743237A condensed anthranilamide insecticides
06/16/2010CN101743229A quinazolinamide derivatives
06/16/2010CN101740723A Organic electroluminescent device and preparation method thereof
06/16/2010CN101735800A Organic electronic transmission and/or hole barrier materials, synthesis method and use thereof
06/16/2010CN101735229A Tetrahydroisoquinoline compounds and preparation method and application thereof
06/16/2010CN101735207A Desloratadine derivative containing gamma-subunit butenolide and synthesizing method thereof
06/16/2010CN101735206A Crystalline form IV of azimilide dihydrochloride, preparation method and application thereof
06/16/2010CN101735205A Crystalline form V of azimilide dihydrochloride, preparation method and application thereof
06/16/2010CN101735204A Crystalline form III of azimilide dihydrochloride, preparation method and application thereof
06/16/2010CN101735203A Azimilide dihydrochloride crystal form II as well as preparation method and application thereof
06/16/2010CN101735202A Azimilide dihydrochloride crystal form I as well as preparation method and application thereof
06/16/2010CN101735201A Preparation method of piribedil
06/16/2010CN101735200A Quinazoline compound
06/16/2010CN101099286B Method and installation means for installing an electrical machine
06/15/2010US7737287 Anomeric derivatives of monosaccharides
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide
06/15/2010US7737166 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides
06/15/2010US7737163 Benzimidazolone carboxylic acid derivatives
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2495577C Novel benzoimidazole derivatives useful as antiproliferative agents
06/15/2010CA2442256C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
06/15/2010CA2379103C Novel spiro compounds
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/10/2010WO2010065877A2 Methods of treating an overweight or obese subject
06/10/2010WO2010065865A2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010WO2010065800A1 Hydrazine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010065799A2 Amine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010065586A2 Preparation of capecitabine
06/10/2010WO2010065449A1 (r) -3- (e) -2- (pyrr0lidin-3-yl) vinyl) -5- (tetrahydr0pyran-4-yl0xy) pyridine, its salts, its synthesis and its use as ligand for nicotinic acetylcholinergic receptors
06/10/2010WO2010065310A1 Inhibitors of diacylglycerol acyltransferase
06/10/2010WO2010064737A1 Heterocyclic compound and use of the same
06/10/2010WO2010064711A1 Pyridine derivative, insecticide for agricultural or horticultural uses comprising the same, and a method for using the insecticide
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064701A1 Pharmaceutical agent comprising quinolone compound
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064300A1 Composition for treatment of esophageal cancer
06/10/2010WO2010063953A2 Novel amino c-xyloside compounds, and cosmetic use
06/10/2010WO2010063666A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010WO2010063610A1 Pyridazinone derivatives
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100145056 Acetyl 2-hydroxy-1,3-diaminoalkanes
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145046 Substituted 3-hydroxy-delta-lactones from epoxides
06/10/2010US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144789 1-Isopropyl-2-Oxo-1,2-dihydropyridine-3-carboxamide Derivatives having 5-HT4 Receptor Agonistic Activity
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/10/2010US20100144741 Ethanolamine derivatives useful as bace inhibitors
06/10/2010US20100144729 Coumarin derivatives
06/10/2010US20100144723 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/10/2010US20100144720 Inhibitors of human tumor-expressed ccxckr2
06/10/2010US20100144716 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100144661 Sodium channel blockers
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/10/2010CA2745015A1 Pharmaceutical agent comprising quinolone compound
06/10/2010CA2744914A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010CA2744708A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/10/2010CA2744489A1 Pyridazinone derivatives
06/10/2010CA2744197A1 Synthesis and novel salt forms of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine
06/10/2010CA2744152A1 Inhibitors of diacylglycerol acyltransferase
06/09/2010EP2194046A1 Triazolone derivative
06/09/2010EP2194041A1 Novel crystal form IX of atorvastatin hemi-calcium and processes for its preparation
1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 694